Company intelligence / Profile preview

Equinom

Ownership: Private
Employees: ~75
Development stage: Commercial

Overview

Equinom develops proprietary non-GMO seed varieties using advanced computational breeding and genomic sequencing. Its Manna™ AI platform provides actionable insights to optimize grain processing efficiency, quality, and profitability. The company’s innovations have led to high-protein soybeans (~58% protein), shatter-resistant sesame seeds, chickpeas, fava beans, mung beans, lentils—all tailored for plant-based food applications. Equinom partners with major ingredient manufacturers like Roquette to advance plant-based protein sources. The Manna™ system has demonstrated significant cost savings for processors.

Industry: Agriculture & AgTech

Partnerships

Roquette

Beyond the preview

Go deeper on Equinom.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Equinom.

Explore the full profile